SCHEMBL10242820

SCHEMBL10242820

C[C@@H]1NC(=O)O[C@@H]1c1cccc(Cl)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
GRM5 P41594 5/20 0.36
PARP1 P09874 2/20 0.33
GSK3B P49841 2/20 0.31
PIM1 P11309 2/20 0.31
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31
AURKA O14965 1/20 0.31
DAPK3 O43293 1/20 0.31
JAK2 O60674 1/20 0.31
PRKD3 O94806 1/20 0.31
MAP4K4 O95819 1/20 0.31
PAK4 O96013 1/20 0.31
ABL1 P00519 1/20 0.31
CSF1R P07333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15743990 0.75 CYP3A4 (0.37) ALOX5CYP3A4TSHRHTR3EHTR3B
SCHEMBL10244710 0.74 ALDH1A1 (0.42) TSHRGRM5PARP1AURKAALDH1A1
SCHEMBL10244194 0.73 GRM5 (0.40) ALOX5TSHRGRM5AURKAALDH1A1
SCHEMBL13413309 0.71 GRM5 (0.39) TSHRGRM5ALDH1A1
SCHEMBL1529100 0.71 GRM5 (0.39) TSHRGRM5ALDH1A1
SCHEMBL13394573 0.71 GRM5 (0.39) TSHRGRM5ALDH1A1
SCHEMBL10243305 0.71 GRM5 (0.39) TSHRGRM5ALDH1A1
SCHEMBL13394575 0.71 GRM5 (0.39) TSHRGRM5ALDH1A1
SCHEMBL12696949 0.71 GRM5 (0.53) ALOX5TSHRGRM5ALDH1A1
SCHEMBL14214703 0.71 GRM5 (0.53) ALOX5TSHRGRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765793-B1 ANACETRAPIB AND OTHER CETP INHIBITPRS MERCK SHARP & DOHME (US) 2012-09-26 EP disclosed
EP-2415759-A1 CETP inhibitors Merck Sharp & Dohme Corporation (US) 2012-02-08 EP disclosed